Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis

2019 
Background This study aimed to explore the molecular mechanism and clinical relevance of iguratimod in the regulation of human B cell terminal differentiation.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    67
    References
    18
    Citations
    NaN
    KQI
    []